James Patrick Zidar MD
Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology
Corporate Chief of Cardiology, REX Healthcare
Join to View Full Profile
2800 Blue Ridge RdSte 400Raleigh, NC 27607
Phone+1 919-787-5380
Dr. Zidar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganResidency, Internal Medicine, 1985 - 1989
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985
Duke University HospitalFellowship, Interventional Cardiology
Certifications & Licensure
NC State Medical License 1990 - 2025
VA State Medical License 2001 - 2004
MI State Medical License 1987 - 1991
American Board of Internal Medicine Internal Medicine
Clinical Trials
- ABSORB III Randomized Controlled Trial (RCT) Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- 1 citationsThe PERFORMANCE II Trial: A Prospective Multicenter Investigation of a Novel Carotid Stent System.William A Gray, D Christopher Metzger, James Zidar, Sasko Kedev, Ivo Petrov
JACC. Cardiovascular Interventions. 2025-02-10 - 11 citationsEffect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinica...David E Kandzari, Michael A Weber, Atul Pathak, James P Zidar, Manish Saxena
Circulation. 2024-06-11 - The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy.Yasin Hussain, Shigeru Saito, Michael Curtis, Dean J Kereiakes, Andreas Baumbach
Journal of the Society for Cardiovascular Angiography & Interventions. 2023-03-27
Press Mentions
Orchestra's Drug-Eluting Balloon Wins FDA Breakthrough Device DesignationSeptember 17th, 2019
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery DiseaseSeptember 17th, 2019
UNC REX Healthcare Recognized for Excellence with ACC HeartCARE Center DesignationMarch 7th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
